News

By Dave Muoio September 23, 2019
Reuters reported on Friday that Fitbit is weighing a sale of its business. While nothing is set in stone, the fitness wearables and health services company is said to have brought on investment firm Qatalyst Partners to explore its options, with the latter pushing for Alphabet or private equity firms as potential buyers. The report pins Fitbit’s new mindset on middling smartwatch success, which...
By Dave Muoio September 23, 2019
Heal, maker of an app for booking and processing device-driven physician house calls, announced today that it has acquired New York City-based Doctors on Call, a roughly 50-year-old provider of house call services for elderly patients. The acquisition allows Heal to expand its services — previously limited to the Atlanta, California and Northern Virginia/Washington D.C. areas — into the New York...
By Laura Lovett September 23, 2019
A Brazilian startup named TNH Health, which makes an artificial intelligence-enabled chatbot, announced a $2 million Series A funding round from Valor Capital Group and individual health entrepreneurs.  Founded in 2013, the company is headquartered in Rio Negrinho, Santa Catrina, Brazil, and has offices in Joinville and São Paulo. WHAT THEY DO The chatbot, dubbed Vitalk, will communicate with...
By Dave Muoio September 23, 2019
NexHealth, maker of a platform that allows doctors to manage online booking, billing and other patient-facing services, has brought in $4.2 million in a round led by Point Nine Capital. Rubicon Venture Capital, Scott Belsky, Josh Hannah and prior backer iSeed Ventures also participated. WHAT THEY DO Based in New York, NexHealth offers a tool that helps practices mange their communications and...
By Dave Muoio September 20, 2019
The US is wading into election season, and once again the healthcare system is a prime focal point for each campaign. And although the subject of “Medicare for All” was certainly present back in 2016, movements to overhaul the country’s insurance industry have gained some steam among voters over the last few years and now command considerable airtime during debates between presidential hopefuls....
By Jonah Comstock September 20, 2019
Eight new digital companies took the stage at Health 2.0’s Annual Conference in San Francisco Wednesday afternoon to give the first public demos of their products for the show’s annual “Launch!” event. OMNY Health, which aims to disrupt data brokerage and give providers more control over the data they sell, took home the audience vote and the $5,000 grand prize. But all eight companies boasted...
By Laura Lovett September 20, 2019
Canadian telemedicine company Maple has landed a cool $14.5 million CAD ($10.9 million USD) in a new funding round. German VC firm Acton Capital led the round, with participation from SE Health.  This news comes less than two years after the company closed a $4 million Series A funding round, which at the time the company said would be used for growth and expansion.  WHAT THEY DO Maple is a...
By Dave Muoio September 20, 2019
As if building the next big thing in healthcare technology wasn’t enough, simply getting an innovation in front of hospital leaders or other decision makers is a monumental task for entrepreneurs. With limited resources and the life of their companies at stake, it’s little surprise that vendors spam providers with countess messages in hopes that one will make it through the barricades of spam...
By Leontina Postelnicu September 20, 2019
London and San Francisco-based digital therapeutics company Big Health has tapped Sir Bruce Keogh, former medical director for NHS England, to join its Advisory Board in an effort to expand access to their products.  Sir Bruce stepped down after 10 years in the national role at the end of 2017 and took up a new position as chair of the Birmingham Women’s and Children’s NHS Foundation Trust....
By Laura Lovett and Dave Muoio September 19, 2019
Former FDA Commissioner Dr. Scott Gottlieb has joined the board of Aetion, a New York City-based real-world evidence analytics platform. Gottlieb, who resigned from his two-year FDA stint in April, had spearheaded the regulatory agency’s recent push to incorporate real-world data into its decision-making processes. "Dr. Gottlieb has played a pivotal role in advancing the use of real-world...

Editor's Pick